2015
DOI: 10.1007/s40290-015-0096-4
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticle-Mediated Delivery of Therapeutic Drugs

Abstract: Nanotechnology-based pharmaceutics is a fast emerging field in the diagnosis and therapy of a number of human diseases, including cancer. Nanoparticles offer a stable means to achieve targeted drug delivery to various cells and tissues. They have been investigated for drug delivery to different tumor tissues, to brain where the blood-brain barrier poses a significant problem in the delivery of effective therapeutic molecules, to ocular tissues and also for eliciting immune response via delivery of vaccines. Pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 132 publications
(138 reference statements)
0
6
0
Order By: Relevance
“…Conventional drug delivery systems are often accompanied with some critical limitations such as high dosage, low efficacy, low bioavailability, lack of target specificity, and dose-dependent side effects (Surendiran et al, 2009;Subramani et al, 2012). In vitro and in vivo investigations showed that nano-drug delivery systems such as nanomicelles, liposomes, and hydrogel-based nanocomposites can provide drug targeting to a specific site (Ponnappan and Chugh, 2015;Kesharwani et al, 2018). In case of diabetes and diabetes-associated dysfunctions, effective delivery of insulin via oral route by these nanoformulations is highly preferred compared to the available parenteral preparations, due to a higher patient compliance (Wilczewska et al, 2012;Fangueiro et al, 2015;Maity et al, 2017).…”
Section: Nano Drug Delivery Systems For Metabolic Syndromementioning
confidence: 99%
“…Conventional drug delivery systems are often accompanied with some critical limitations such as high dosage, low efficacy, low bioavailability, lack of target specificity, and dose-dependent side effects (Surendiran et al, 2009;Subramani et al, 2012). In vitro and in vivo investigations showed that nano-drug delivery systems such as nanomicelles, liposomes, and hydrogel-based nanocomposites can provide drug targeting to a specific site (Ponnappan and Chugh, 2015;Kesharwani et al, 2018). In case of diabetes and diabetes-associated dysfunctions, effective delivery of insulin via oral route by these nanoformulations is highly preferred compared to the available parenteral preparations, due to a higher patient compliance (Wilczewska et al, 2012;Fangueiro et al, 2015;Maity et al, 2017).…”
Section: Nano Drug Delivery Systems For Metabolic Syndromementioning
confidence: 99%
“…Thus, a chimeric combination of a Latarcin 1‐derived spider toxin peptide (KWRRKLKKLR) with a nuclear localisation sequence from Simian virus T antigen yielded a novel CPP LDP‐NLS (KWRRKLKKLRPKKKRKV), capable of protein delivery. [ 22 ] Various linear fragments of crotamine, a cationic antimicrobial toxin polypeptide from the rattlesnake Crotalus durissus , including C1 (KQCHKKGGHCFPKEKIC), are also effective CPP vectors. [ 23 ] Of the many hundreds of CPPs described to date [ 16 ] a majority are now mostly confined to the annals of history; they provide structural clues useful for the development and prediction of more efficient CPP vectors, but many are essentially evolutionary dead‐ends.…”
Section: Identification and Sources Of Cpps And Bioportidesmentioning
confidence: 99%
“…These micelles have a narrow size distribution therefore, they offer advantages in the encapsulation of lipophilic or even insoluble drugs. The size of micelles can vary from 20 to 200 nm, ensuring good penetration of blood vessels and long-lasting distribution in the body [36].…”
Section: Introductionmentioning
confidence: 99%